Categories: Wire Stories

Announcement of Agaricus blazei mushroom, KA21 strain�s Ability to Improve QOL of Athletes at Annual Meeting, Toei Shinyaku

Athlete performance, overall condition, quality of sleep, sense of fatigue, mental condition, concentration ability, muscle condition, stamina, and resilience.

TOKYO–(BUSINESS WIRE)–Toei Shinyaku gave an academic presentation regarding Agaricus blazei KA21 strain�s ability to improve QOL of athletes at the 22nd Annual Meeting of the Japanese Society of Anti-Aging Medicine. Human clinical trials confirmed the effects of Agaricus blazei KA21 strain on athlete performance, overall condition, quality of sleep, sense of fatigue, mental condition, concentration ability, muscle condition, stamina, and resilience.

About Agaricus blazei, brasiliensis, subrufescens

Agaricus blazei (also known as A. brasiliensis, A. subrufescens) is a medicinal mushroom. It is popular primarily in Asian countries (particularly Japan) as an ingredient of immune booster used in complementary and alternative medicine (CAM). Characteristics of Agaricus blazei such as safety and effectiveness vary significantly depending on the strain, cultivation method, and production region.

Agaricus KA21 (Common name: King Agaricus)

Agaricus KA21 is Agaricus blazei KA21 strain cultivated outdoors in Brazil under direct sunlight. Compared to regular Agaricus blazei cultivated in a dark greenhouse, Agaricus KA21 is large in size, contains an abundance of major ingredients such as beta-glucan and vitamin D, and offers an antioxidant activity level over five times greater. Outdoor cultivation is extremely difficult with small yield, therefore Agaricus KA21 is a rare commodity. Toei Shinyaku is the sole company in the world that sells it.

Toei Shinyaku Co.,Ltd.

Established in 1973, Toei Shinyaku is a Japanese manufacturer that specializes in R&D activities, as well as the manufacture and sale of Agaricus KA21. Toei Shinyaku has conducted research on Agaricus KA21 for over 25 years and presented 32 international papers on its findings; making it the company with the greatest research results out of all Japanese Agaricus blazei manufacturers. Toei Shinyaku discloses evidence supporting its product, Agaricus KA21, on its official homepage. Details include the safety of human clinical trials of Agaricus KA21, ability to strengthen the immune system, alleviate fatigue, improve hair loss and gray hair, and prevent fungal infection. Data also includes the effect of Agaricus KA21 found through trials on mice; such as reducing side effects of anticancer drugs, hair growth benefits, and enhanced wound healing.

Contacts

Toei Shinyaku Co.,Ltd.

Akitomo Motoi

info@toeishinyaku.jp
Cross-Border EC website: www.toeishinyaku.jp
For business inquiry including wholesales and OEM: www.agaricus.co.jp
Main Products: Akkerman Slim etc.

Alex

Recent Posts

Cheers to New Beginnings: Carlsberg Hong Kong Launches No & Low-Alcohol and Beyond Beer Series for Conscious Celebrations

Ringing in the New Year, the extended collection promotes moderation and conscious drinking throughout the…

7 hours ago

The 27th Mountain Emei Ice, Snow & Hot Spring Season Invites Global Visitors to “Enjoy Winter Fun”

EMEISHAN, CHINA - Media OutReach Newswire - 16 December 2025 - On the evening of…

7 hours ago

Lily Allen, Little Simz and Bianca Bustamante Light Up The Red-Carpet In Desert Diamonds, At The Fashion Awards 2025

LONDON, UK - Media OutReach Newswire - 16 December 2025 - Desert diamonds graced the…

8 hours ago

ISCA Unveils Bold Plan to Future-Proof Singapore’s Small and Medium-Sized Accounting Practices

SINGAPORE - Media OutReach Newswire - 16 December 2025 - Small and Medium-Sized Accounting Practices…

11 hours ago

Leeds Capital and MIO Trust Are Proud to Announce Their Collaboration on an AI‑Driven Multi‑Asset Trust Focused on Digital Assets and Precious Metals

SYDNEY, AUSTRALIA - Media OutReach Newswire - 16 December 2025 - Leeds Capital and MIO…

12 hours ago

Optimistic Hong Kong Ecommerce Merchants Report Growth, But Hidden Payment Friction Is Eroding Up to 10% of Revenue, Aspire Report Finds

Despite 64% reporting revenue growth, 91% of merchants face payment friction HONG KONG SAR -…

13 hours ago